ARYA Sciences Acquisition Corp V: auditor change — ARYA Sciences SPAC restates Q3 2022 financials, cites accounting error on deferred commissions

ARYA Sciences Acquisition Corp V

Received underwriter waiver of 50% deferred commissions on Aug 8, 2022; previously recognized as extinguishment gain, now as credit to shareholders' deficit.
Restatement covers Q3 2022 (Sept 30, 2022); no impact on cash, trust investments, operating expenses, or cash flows.
Material weakness in internal control over financial reporting and ineffective disclosure controls identified for affected period.
Audit Committee concluded on April 11, 2023 that prior statements should no longer be relied upon; restatement to be filed in 2022 10-K.

item 4.02

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ARYA Sciences Acquisition Corp V reported that prior financial statements should not be relied upon.

Action: non reliance

Exact text from the filing

the Company's management and the Audit Committee of the Company's Board of Directors (the "Audit Committee") concluded on April 11, 2023 that the financial statements for the Affected Period (as defined below) included in the Quarterly Report should no longer be relied upon

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001140361-23-017819

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.